EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules
Theranostics · 2023 · 13 (2) · 458-471
DOI: 10.7150/thno.78395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Yue Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Nasopharyngeal Neoplasms, T-Lymphocytes, Cytotoxic. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong SAR, China.
- Department of Chemistry, Faculty of Science, Hong Kong Baptist University, Hong Kong SAR, China.
- Center for Medical Innovation, Nagasaki University, Nagasaki, Japan.
Zitieren
APA
Liu, Y., Lui, K. S., Ye, Z., Fung, T. Y., Chen, L., Sit, P. Y., Leung, C. Y., Mak, N. K., Wong, K. L., Lung, H. L., Tanaka, Y., & Cheung, A. K. L. (2023). EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules. Theranostics, 13(2), 458-471. https://doi.org/10.7150/thno.78395
Vancouver
Liu Y, Lui KS, Ye Z, Fung TY, Chen L, Sit PY, et al. EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules. Theranostics. 2023;13(2):458-471. doi:10.7150/thno.78395
BibTeX
@article{Liu2023,
author = {Liu, Yue and Lui, Ka Sin and Ye, Zuodong and Fung, Tsz Yan and Chen, Luo and Sit, Ping Yiu and Leung, Chin Yu and Mak, Nai Ki and Wong, Ka-Leung and Lung, Hong Lok and Tanaka, Yoshimasa and Cheung, Allen Ka Loon},
title = {EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules},
journal = {Theranostics},
year = {2023},
volume = {13},
number = {2},
pages = {458--471},
doi = {10.7150/thno.78395}
}
EUVIMED